Renovacare Inc (RCAR) 2.1754 $RCAR CORRECTING and

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Renovacare Inc (RCAR) 2.1754 $RCAR

CORRECTING and REPLACING VIDEO Latest Test Results Bolster RenovaCare Strategy to Spray Stem Cells on Wounds and Burns for Rapid Healing
BusinessWire - Tue May 31, 10:29AM CDT
Please replace the video with the accompanying corrected video.

Latest Test Results Bolster RenovaCare Strategy to Spray Stem Cells on Wounds and Burns for Rapid Healing
BusinessWire - Tue May 31, 8:57AM CDT
RenovaCare, Inc., (OTCQB:RCAR) today announced positive spray test results demonstrating that its novel SkinGun(TM) technology achieves exceptionally-uniform distribution of fluids with 200 times greater coverage than conventional methods. These outcomes are especially promising to scientists developing patented RenovaCare CellMist(TM) and SkinGun(TM) technologies* for spraying fluids containing a patient's own stem cells onto burns and wounds for rapid scar-free healing.

New Study: RenovaCare SkinGun(TM) Ultra-Gently Sprays Human Stem Cells to Achieve 'Gold-Standard' Viability for Skin Regeneration
BusinessWire - Tue May 03, 8:15AM CDT
RenovaCare, Inc., (OTCQB:RCAR), a developer of novel medical grade liquid spray devices and patented CellMist(TM) and SkinGun(TM) technologies*, today announced favorable outcomes from laboratory studies conducted by Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charite - Universitatsmedizin Berlin, one of the world's largest university hospitals.

RenovaCare, Inc. Completes Engineering, Research, and Studies Required to File 510(k) Submission to the FDA for its Novel Medical-Grade Liquid Spray Device
BusinessWire - Tue Apr 12, 8:15AM CDT
RenovaCare, Inc., a developer of novel medical grade liquid spray devices and patented CellMist(TM) and SkinGun(TM) technologies* for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced that the company has successfully completed the engineering, studies, and associated efforts required for submission of its foundational 510(k) filing to the U.S. Food and Drug Administration (FDA). The company's planned submission will focus on its liquid sprayer technology. The FDA's clearance of a 510(k) submission allows for the marketing of a medical device in the United States.

RenovaCare, Inc. Names Renowned Skin Surgeon Steven Q. Wang, MD to Board of Advisors
BusinessWire - Tue Feb 09, 8:15AM CST
RenovaCare, Inc., developer of patented CellMist(TM) and SkinGun(TM) technologies* for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of Steven Q. Wang to its Board of Advisors. Dr. Wang is Head of Dermatology Section and Director of Dermatologic Surgery and Dermatology at Memorial Sloan-Kettering Cancer Center in Basking Ridge, New Jersey.

Respected Plastic and Reconstructive Surgeon, Richard Simman, MD, Joins RenovaCare, Inc.
BusinessWire - Tue Jan 12, 8:15AM CST
RenovaCare, Inc., developer of the patented CellMist(TM) and SkinGun(TM) technologies* for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of board certified plastic and reconstructive surgeon, Richard Simman, MD, FACS, and FACCWS, to its Board of Advisors.

RenovaCare, Inc. Enters R&D Partnership with World Leading Charite
BusinessWire - Tue Nov 17, 8:15AM CST
RenovaCare, Inc. (OTCQB:RCAR), today announced a partnership to validate the science behind its groundbreaking technology for treatments of wounds, burns and other skin defects. The company's research partner is Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charite - Universitatsmedizin Berlin, one of the world's largest university hospitals.

RenovaCare elects Michael M. Barch to board of advisors
M2 - Fri Oct 16, 3:06AM CDT
Stem cell therapies company RenovaCare (OTC BB:RCAR) reported on Thursday the addition of Michael M. Barch to its board of advisors.

Accomplished Healthcare Executive, Michael M. Barch, Joins RenovaCare, Inc.
BusinessWire - Thu Oct 15, 8:15AM CDT
RenovaCare, Inc., (OTCQB:RCAR), developer of the patented CellMist(TM) and SkinGun(TM) technologies for isolating and spraying a patient's own stem cells onto burns and wounds for rapid self-healing, today announced the appointment of healthcare executive and industry thought-leader, Michael M. Barch, to its Board of Advisors.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Everest Group Faces Major Class Action Deadline Looms

Updated Category News Views 112

Everest Group's Headaches Multiply as Deadline Approaches Well, here we find a classic case of Wall Street drama—Everest Group, Ltd. (NYSE:EG), a company whose troubles would make any trader weary. As of late, it's caught up in a nasty class-action lawsuit with stakes high enough to raise eyebrows from Broadway to Bayou. Investors in Everest better be tuned in, because...

Continue Reading
Zillow Set for Major Talks at RBC Capital Markets Conference

Updated Category News Views 130

Zillow Group Prepares for a Key Presentation Turning heads again, Zillow Group, a heavyweight in real estate innovation, is gearing up for a spotlight moment. Come November 17, they're taking the stage at the RBC Capital Markets Global Technology, Internet, Media & Telecommunications Conference in the Big Apple. Now, these corporate shindigs aren't always a ticker...

Continue Reading
AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 110

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading
Pen Needles Market to Hit $3.37B by 2031: Growth Ahead

Updated Category News Views 144

Big Numbers in the Needle Game When you're staring down the numbers popping out of this pen needles market projection, it's hard to ignore—shooting from a respectable $2.16 billion in 2026 to a hefty $3.37 billion by 2031. We're talking a 9.3% CAGR that'll have investors pulling out their calculators or maybe rubbing their hands in downright glee, depending on their...

Continue Reading
Cognizant Grabs Wizeline: A Power Play in Digital

Updated Category News Views 132

An Acquisition with Strategic Weight Cognizant's just bagged a beast, folks. The purchase of Wizeline marks a hefty step for NASDAQ:CTSH in the ever-evolving landscape of digital engineering and AI. It's not the kind of strategic move you see every day. The Wizeline Asset: What Stands Out? Wizeline isn't just window dressing. It's a heavy hitter in AI-native digital...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
MNTN Revenue Miss Sparks Shareholder Investigation

Updated Category News Views 79

When Revenue Goes South, Shares Follow Nothing like a Friday morning stock bloodbath to shake things up. MNTN, Inc. (NYSE:MNTN) had traders tossing back extra caffeine shots on November 5, 2026, when the company reported third-quarter revenues of $80.3 million. Let's just say that number didn't quite sit well with the folks who'd been banking on an $87.7 million...

Continue Reading
Yiren Digital's Tumble: Lawsuit Timeline for Investors

Updated Category News Views 82

Yiren's Stock Plunge and the Legal Quagmire What a mess Yiren Digital Ltd. (NYSE:YRD) finds itself in, huh? We're looking at a stunning 44.05% stock nosedive that's left a trail of bruised investors in its wake. Now that's a real gut-punch for any portfolio hugging YRD. So, what's spinning this cycle of chaos for our digital player from across the pond? The Flash Point:...

Continue Reading
Recovery 180's Landmark Facility: Community Impact Unfolds

Updated Category News Views 85

Taneytown Takes a Significant Leap Well, Taneytown's making noise, folks. Never thought this sleepy spot would pull off something so important, but here we are with Recovery 180 opening Taneytown’s first-ever residential Level 3.1 treatment facility. After four years of struggle, the largest venture in Carroll County is opening its doors to residents who desperately...

Continue Reading
Sussex County Data Breach Raises Security Concerns

Updated Category News Views 95

The Digital Fiasco: A Wake-Up Call Straight out of Sussex County in good ol' New Jersey, we’re staring down another data breach, folks. When you hear about a data privacy incident, there's always that same sinking feeling of another layer of personal security peeled away. This time, the Sussex County Prosecutor's Office got caught in the crossfire, with personal info...

Continue Reading

Top 5 Most Recently Viewed Articles

Planful Welcomes Richard Parke as New Customer Experience Leader

Updated Category News Views 324

Planful Announces the Appointment of Richard Parke In an exciting move for customer engagement, Planful Inc., recognized as a leader in financial performance management cloud software, has announced the appointment of Richard Parke as its Chief Customer Officer. Richard joins the company at a time when Planful is experiencing rapid global expansion and aims to enhance...

Continue Reading
Chlorine Market Growth Forecast: Insights and Trends

Updated Category News Views 87

Chlorine Market Growth Forecast and Trends The global chlorine market is poised for steady growth, with a compound annual growth rate (CAGR) projected at 4.5% through 2034. By that time, the market is expected to reach a valuation of USD 24.19 billion, up from USD 15.58 billion in 2024. Key Growth Drivers of the Chlorine Market One of the main factors driving the growth...

Continue Reading
Transforming Healthcare: Clinical Decision Support Systems Growth

Updated Category News Views 178

Healthcare Transformation Through Clinical Decision Support Systems The global landscape of healthcare is rapidly evolving, significantly influenced by Clinical Decision Support Systems (CDSS). With a valuation projected to reach USD 3.89 billion by the end of the forecasted period, the CDSS market is more than just a trend; it's a transformative force in health delivery...

Continue Reading
EnWave Welcomes Louise Lalonde to Board, Bidding Farewell to Ritchie

Updated Category News Views 118

EnWave Corporation Strengthens Leadership with New Appointment EnWave Corporation (TSX-V:ENW | FSE:E4U) recently made a significant update to its Board of Directors by appointing Ms. Louise Lalonde, a seasoned professional in accounting and compliance, who will also take on the vital role of Audit Committee Chair. Ms. Lalonde brings over 30 years of extensive experience...

Continue Reading
UIL Limited Achieves Modest NAV Growth and Market Insights

Updated Category News Views 137

UIL Limited's NAV Performance and Market Overview UIL Limited (LEI Number: 213800CTZ7TEIE7YM468) has recently released its monthly factsheet highlighting a modest yet positive net asset value (NAV) total return of 0.4% for December. This performance notably outshined the FTSE All Share total return Index, which experienced a decrease of 1.2% during the same time frame....

Continue Reading